{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:22:29Z","timestamp":1761744149267},"reference-count":17,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"Medical Research Council with Eli Lilly and Company Ltd"},{"name":"European Community\u2019s Seventh Framework Programme","award":["279227"],"award-info":[{"award-number":["279227"]}]},{"name":"Marie Curie Industry\u2013Academia Partnership and Pathways","award":["286213"],"award-info":[{"award-number":["286213"]}]},{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre"},{"name":"Maudsley NHS Foundation Trust and King\u2019s College"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.2217\/pgs.15.67","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T08:25:16Z","timestamp":1435652716000},"page":"915-917","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["How Close are We to a Pharmacogenomic Test for Clozapine-Induced Agranulocytosis?"],"prefix":"10.1080","volume":"16","author":[{"given":"Moira","family":"Verbelen","sequence":"first","affiliation":[{"name":"MRC SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathryn M","family":"Lewis","sequence":"additional","affiliation":[{"name":"MRC SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK"},{"name":"Department of Medical & Molecular Genetics, King\u2019s College London, 8th Floor Tower Wing, Guy\u2019s Hospital, Great Maze Pond, London, SE1 9RT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,6,30]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.6.576"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.483"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.3371\/CSRP.6.3.5"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11r06977"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307153290303"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.8.1101"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-011-0185-3"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05527yel"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2013.74"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5757"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.182"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2014.16.4\/jpouget"},{"key":"e_1_3_2_14_1","article-title":"Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis","author":"Verbelen M","year":"2015","unstructured":"Verbelen M , CollierDA , CohenD , MaccabeJH , LewisCM . Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis . Pharmacogenomics J. ( 2015 ).","journal-title":"Pharmacogenomics J."},{"key":"e_1_3_2_15_1","unstructured":"US Food and Drug Administration . Table of pharmacogenomic biomarkers in drug labeling ( 2015 ). www.fda.gov\/Drugs\/ScienceResearch\/ResearchAreas\/Pharmacogenetics\/ucm083378.htm ."},{"key":"e_1_3_2_16_1","unstructured":"Pharmgkb . Drug labels ( 2015 ). www.pharmgkb.org\/view\/drug-labels.do ."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064683"},{"key":"e_1_3_2_18_1","unstructured":"Crestar . Crestar \u2013 development of pharmacogenomic biomarkers for schizophrenia ( 2015 ). www.crestar-project.eu ."}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.15.67","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:12:27Z","timestamp":1715973147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.15.67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.2217\/pgs.15.67"],"URL":"https:\/\/doi.org\/10.2217\/pgs.15.67","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-06-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}